EST
GILD icon

EA Series Trust’s Gilead Sciences GILD Stock Holding History

EA Series Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$2.03M Buy
+26,365
New +$2.1M 0.07% 388

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EA Series Trust's GILD Position: Q2 2023 in Review

EA Series Trust opened a new position in Gilead Sciences (GILD) in Q2 2023: 26,365 shares worth $2.03M. The stake represents 0.07% of the portfolio and ranks #388 among its holdings.

1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • EA Series Trust held 26,365 shares of Gilead Sciences worth $2.03M as of Q2 2023.
  • Gilead Sciences was a new EA Series Trust position in Q2 2023.
  • Gilead Sciences made up 0.07% of EA Series Trust's portfolio in Q2 2023, its #388 holding.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.